International variation in medication prescription rates among elderly patients with inflammatory bowel disease.

摘要: Abstract Background and aims The elderly represent a growing demographic of patients with IBD. No study has previously described variations in care or medication prescriptions senior We compared prescription rates among IBD four countries using health administrative data. Methods Databases from the United States (US), Kingdom (UK), Denmark Canada were queried. Variation between was assessed ≥ 65 y prevalent who had ≥ 1 for an IBD-related given quarter 2004 2009. Patients identified previously-reported, validated algorithms. Country-specific each Fisher's exact test. Results In Crohn's disease, US higher oral 5-ASA (P  Conclusions Significant variation exists countries. Future research should assess whether these differences associated disparities outcomes costs.